Evolv (EVLV) Insider Plans Sale of 242K Class A Shares on Nasdaq

Rhea-AI Filing Summary

Evolv Technologies Holdings, Inc. (EVLV) submitted a Form 144 disclosing a proposed sale of 242,235 Class A common shares through J.P. Morgan Securities LLC on 09/15/2025 on Nasdaq with an aggregate market value of $2,124,401. The filing shows these shares were acquired and paid for on 09/15/2025 via a stock option exercise and payment in cash. The filer reports 171,891,467 shares outstanding and states there were no sales in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full transaction disclosure including broker, quantity, market value, and exchange
• Acquisition method specified as a stock option exercise with payment in cash
• No sales in prior three months reported for the selling person

Negative

• None.

Insights

Securities Analyst

TL;DR Clear disclosure of an executive-level option exercise and intended sale; not an earnings event.

The Form 144 provides specific transaction-level detail: 242,235 Class A shares to be sold through J.P. Morgan on 09/15/2025, acquired the same day by stock option exercise and paid in cash. The filing notes 171,891,467 shares outstanding and no sales in the prior three months, which helps contextualize the size of the proposed sale. This is a routine insider liquidity disclosure rather than an operational update.

Corporate Governance Expert

TL;DR Routine compliance filing showing an insider exercising options and notifying market of planned sale.

The notice contains the required representations under Rule 144 and a declaration the seller is unaware of undisclosed material adverse information. It also documents the mechanics of acquisition and payment (option exercise paid in cash) and names the broker. From a governance perspective, the filing meets standard transparency requirements for insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	242235	2124401	171891467	09/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/15/2025	Stock option exercise	Issuer			242235	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the EVLV Form 144 disclose for sale?

The filing discloses a proposed sale of 242,235 Class A common shares.

When and where is the EVLV sale planned to occur?

The sale is planned on 09/15/2025 through J.P. Morgan Securities LLC on Nasdaq.

How were the shares acquired according to the Form 144 for EVLV?

The shares were acquired on 09/15/2025 by a stock option exercise and paid in cash.

What is the aggregate market value and outstanding share count listed?

Aggregate market value is listed as $2,124,401 and shares outstanding are 171,891,467.

Does the filer report other sales in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.